World of DTC Marketing

JULY 28, 2022

Still, the pharma industry is fighting hard to keep it off the table. Late last year, the Senate Finance Committee released draft legislation enabling Medicare negotiation for up to 10 drugs in 2025, 15 in 2026 and 2027, and 20 in 2028 and beyond. Pharma is a very profitable industry. The secretary of the U.S.

Pharma 256

Pharma Prescription Pharmaceutical Manufacturing 256

World of DTC Marketing

DECEMBER 15, 2021

Together with the growth in wearables—projected to be worth nearly $120 billion by 2028—we are seeing growing democratization of knowledge of one’s own body, with tech enabling consumers to take a more active and regular role in their healthcare. Physicians have not bought into the hype around apps. The Economist.

Doctors 208

Doctors Medical Patients Marketing 208

Pharmaceutical Technology

SEPTEMBER 2, 2022

Since the frontline treatment setting is dominated by these regimens, pharma companies have focused on the development of new drugs in the relapsed/refractory (R/R) setting. However, the lack of mature overall survival data for either agent means physicians will have to select therapy based on attributes other than long-term efficacy.

Food and Drug Administration 59

Food and Drug Administration Sales FDA Marketing 59

Pharmaceutical Representative Training

JANUARY 29, 2025

The approval of new biosimilars and the process of finding a place for them in the healthcare space will have its own set of challenges: Physician Trust: Biologics are more well-known and trusted by physicians who have been exposed to them for years. Starting in 2019, the US market was valued at $4.5 4] References: 1.

Marketing 52

Marketing Healthcare Healthcare Physicians 52

Clarivate

OCTOBER 25, 2023

The dearth of cancer drugs (only blood cancer drug Imbruvica made this first list) stems from CMS only pursuing negotiations for Part D drugs in 2026 and 2027, then expanding to Part B drugs in 2028. Part D cannot cover drugs covered under Part A or Part B , forcing them to be addressed separately.

Prescription 52

Prescription Physicians Manufacturing Healthcare 52

PM360

APRIL 7, 2023

No one has ever described the pharma market access landscape as simple or easy to understand, and the passage of the Inflation Reduction Act (IRA) is not likely to change that. Pharma manufacturers of brands that are selected for negotiation will absolutely want to ‘pull through’ their coveted, newfound formulary position with HCPs.

Marketing 52

Marketing Pharma Manufacturing Healthcare 52

Medico Reach

JUNE 16, 2022

trillion by 2028. The healthcare industry is currently undergoing a paradigm shift, and with a technology-enabled healthcare model in place, the role of general physicians will change forever. billion Pharma: $169.9 The industry was worth around 19.7% of the US GDP in 2020. The US national healthcare expenditure for 2020 was $4.1

Healthcare 98

Healthcare Healthcare Distribution Healthcare Provider 98